来自MSN9 个月
Drug development advances in beneficial loss-of-function mutation targets validated by ...
HSD17B13 is involved in hepatic lipid metabolism and is one of the emerging potential targets for NAFLD/NASH, with three drugs currently in Phase II clinical stage (ARO-HSD, ALN-HSD and FOR-6219).
Medscape7 天
Current Management of Patients With Nonalcoholic Fatty Liver Disease
Inclusion of pathogenic mechanisms in treatment design will allow future therapies to target-specific pathways involved in NAFLD pathogenesis. This review will focus on the current status of NAFLD ...
News Medical on MSN8 天
New drug approach shows promise in treating metabolic liver diseases
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
Medical Xpress on MSN8 天
Promising therapeutic approach for metabolic liver diseases
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...
来自MSN17 天
FDA Approves First Fatty Liver Disease Drug: Who It's For and How It Works
How the FDA-approved fatty liver disease drug works Meant to be used in conjunction with a healthy diet and exercise, Rezdiffra is designed to treat people with NASH with moderate to advanced ...
EurekAlert!9 天
Promising therapeutic approach for metabolic liver diseases
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver ... formerly known as non-alcoholic fatty liver disease (NAFLD)) is the most common and rapidly ...
Yahoo17 天
FDA Approves First Fatty Liver Disease Drug: Who It’s For and How It Works
Rezdiffra can be helpful for those who meet the qualifications. Some insurance plans will partially cover the fatty liver disease drug, but there may still be significant out-of-pocket costs—and ...
Medical Xpress9 天
Fatty Liver Disease
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver ... formerly referred to as nonalcoholic fatty liver disease (NAFLD), impacts roughly 30% of the ...
Yahoo Finance1 个月
New Target RWE Research Validates Updated Liver Disease Terminology in Children
Target RWE's deep longitudinal and cross-sectional patient journeys support precise decision-making, driving innovation in drug development ... 100% of patients with NAFLD cirrhosis met the ...